Knockdown of RBBP6 enhances radiosensitivity of gastric cancer cells through p53 pathway

[1]  D. Sanli,et al.  Outcomes after combined right hemicolectomy and pancreaticoduodenectomy for locally advanced right-sided colon cancer: a case series , 2020 .

[2]  Y-j Liu,et al.  RBBP6 aggravates the progression of ovarian cancer by targeting PIK3R6. , 2020, European review for medical and pharmacological sciences.

[3]  Zheng Zhang,et al.  Identification of Key Genes in Gastric Cancer by Bioinformatics Analysis , 2020, BioMed research international.

[4]  Shiqin Wei,et al.  RBBP6 induces non-small cell lung cancer cell proliferation and high expression is associated with poor prognosis , 2020, Oncology letters.

[5]  Yiping Wang,et al.  Cisplatin resistance in gastric cancer cells is involved with GPR30‐mediated epithelial‐mesenchymal transition , 2020, Journal of cellular and molecular medicine.

[6]  Xin Zhang,et al.  RBBP6, a RING finger-domain E3 ubiquitin ligase, induces epithelial–mesenchymal transition and promotes metastasis of colorectal cancer , 2019, Cell Death & Disease.

[7]  T. Satoh,et al.  Abnormal accumulation of p53 predicts radioresistance leading to poor survival in patients with endometrial carcinoma , 2019, Oncology letters.

[8]  Z. Mbita,et al.  Expression Analysis of RbBP6 in human cancers: a Prospective biomarker. , 2019, Anti-cancer drugs.

[9]  Jie Li,et al.  SDH5 Depletion Enhances Radiosensitivity by Regulating p53: A New Method for Noninvasive Prediction of Radiotherapy Response , 2019, Theranostics.

[10]  Yuehua Wu,et al.  B7-H3 increases the radioresistance of gastric cancer cells through regulating baseline levels of cell autophagy. , 2019, American journal of translational research.

[11]  C. Diaconu,et al.  Recent advances in gastric cancer early diagnosis , 2019, World journal of gastroenterology.

[12]  S. Naicker,et al.  RBBP6 Is Abundantly Expressed in Human Cervical Carcinoma and May Be Implicated in Its Malignant Progression , 2019, Biomarkers in cancer.

[13]  Hong Zhang,et al.  RBBP6 increases radioresistance and serves as a therapeutic target for preoperative radiotherapy in colorectal cancer , 2018, Cancer science.

[14]  Gang Li,et al.  Prediction of radiosensitive patients with gastric cancer by developing gene signature , 2017, International journal of oncology.

[15]  S. Akiba,et al.  Radiation-induced Epstein–Barr virus reactivation in gastric cancer cells with latent EBV infection , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[16]  M. Ntwasa.  Retinoblastoma Binding Protein 6, Another p53 Monitor. , 2016, Trends in cancer.

[17]  P. Moela,et al.  RBBP6: a potential biomarker of apoptosis induction in human cervical cancer cell lines , 2016, OncoTargets and therapy.

[18]  H. Wanibuchi,et al.  Comparative Proteomics Analysis of Gastric Cancer Stem Cells , 2014, PloS one.

[19]  Z. Dlamini,et al.  Expression and function of retinoblastoma binding protein 6 (RBBP6) in human lung cancer. , 2011, Immunobiology.

[20]  K. Somasundaram,et al.  Role of p53 status in chemosensitivity determination of cancer cells against histone deacetylase inhibitor sodium butyrate , 2005, International journal of cancer.

[21]  H. Chung,et al.  Growth inhibitory effects of trastuzumab and chemotherapeutic drugs in gastric cancer cell lines. , 2004, Cancer letters.

[22]  W. El-Deiry.  The role of p53 in chemosensitivity and radiosensitivity , 2003, Oncogene.

[23]  Zhang Shan-wen,et al.  Effect of adenovirus-mediated p53 gene transfer on apoptosis and radiosensitivity of human gastric carcinoma cell lines , 2003 .

[24]  D. Ilson.  Advances in the treatment of gastric cancer , 2017, Current opinion in gastroenterology.

[25]  Firdous Khan,et al.  Implications of RBBP6 in various types of cancer , 2014, IWBBIO.

[26]  C. Earle,et al.  Neoadjuvant or adjuvant therapy for resectable gastric cancer: a systematic review and practice guideline for North America , 2012, Gastric Cancer.

[27]  J. Roth,et al.  Thep53 gene is a potent determinant of chemosensitivity and radiosensitivity in gastric and colorectal cancers , 2005, Journal of Cancer Research and Clinical Oncology.